Skip to Main Content

Paper Details

Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab.
Clin Cancer Res
29
2020
Author NameAffiliation
Elizabeth Garrett-MayerAmerican Society of Clinical Oncology
  • 1 - 1

Datasets

Release 1.2